Abstract: The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, methods of using the same, processes for preparing the same, and intermediates thereof.

Abstract: The system, method and program of the invention enables a new DTD to be dynamically created during runtime from a preexisting DTD. A next document is processed and validated according to the new DTD. An interface is provided that enables plug-in providers to provide fragments of DTD information for at least one new element to be added and the name of the element that is to be added to an existing parameter entity. All of the fragments from each plug-in provider are concatenated together and combined with the static header information of the preexisting DTD to form the new DTD.

Abstract: The present invention relates to the gemcitabine prodrug 1-(2,2-difluoro-2-deoxy-?-D -ribofuranosyl)-4-(2-propyl-1-oxopentyl)aminopyrimidin-2-one useful as an oral drug for the treatment of cancer.

Abstract: The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, methods of using the same, processes for preparing the same, and intermediates thereof.

Abstract: The system, method and program of the invention enables a new DTD to be dynamically created during runtime from a preexisting DTD. A next document is processed and validated according to the new DTD. An interface is provided that enables plug-in providers to provide fragments of DTD information for at least one new element to be added and the name of the element that is to be added to an existing parameter entity. All of the fragments from each plug-in provider are concatenated together and combined with the static header information of the preexisting DTD to form the new DTD.

Abstract: The present invention relates to novel amide prodrugs of gemcitabine, compositions thereof and methods for using.

Abstract: The method enables a new DTD to be dynamically created during runtime from a preexisting DTD. A next document is processed and validated according to the new DTD. An interface is provided that enables plug-in providers to provide fragments of DTD information for at least one new element to be added and the name of the element that is to be added to an existing parameter entity. All of the fragments from each plug-in provider are concatenated together and combined with the static header information of the preexisting DTD to form the new DTD.

Abstract: The system, method and program of the invention enables a new DTD to be dynamically created during runtime from a preexisting DTD. A next document is processed and validated according to the new DTD. An interface is provided that enables plug-in providers to provide fragments of DTD information for at least one new element to be added and the name of the element that is to be added to an existing parameter entity. All of the fragments from each plug-in provider are concatenated together and combined with the static header information of the preexisting DTD to form the new DTD.

Abstract: The present invention provides certain monofluoroalkyl derivatives useful for potentiating glutamate receptor function in a mammal and therefore, useful for treating a wide variety of conditions, such as psychiatric and neurological disorders.

Abstract: The present invention provides compounds of formula (I), useful for potentiating glutamate receptor function in a mammal and therefore, useful for treating a wide variety of conditions, such as psychiatric and neurological disorders.

Abstract: The system, method and program of the invention enables a new DTD to be dynamically created during runtime from a preexisting DTD. A next document is processed and validated according to the new DTD. An interface is provided that enables plug-in providers to provide fragments of DTD information for at least one new element to be added and the name of the element that is to be added to an existing parameter entity. All of the fragments from each plug-in provider are concatenated together and combined with the static header information of the preexisting DTD to form the new DTD.

Abstract: The present invention provides certain amide, carbamate and urea derivatives useful for potentiating glutamate receptor function in a mammal and therefore, useful for treating a wide variety of conditions, such as psychiatric and neurological disorders.

Abstract: The present invention is related to “trace” and debugging capability in the operation of the Java programming utility. It represents a means to execute a program in such a way that the sequence of statements being executed can be observed. It is related to “debugger”, which is a program designed to aid in debugging another program by allowing the programmer to step through the program, examine the data and monitor conditions, such as the values of the variables, and correct the problem.

Abstract: The present invention relates to the potentiation of glutamate receptor function using certain sulphonamide derivatives. It also relates to novel sulphonamide derivatives, to processes for their preparation and to pharmaceutical compositions containing them.

Abstract: The present invention relates to the potentiation of glutamate receptor function using certain sulphonamide derivatives. It also relates to novel sulphonamide derivatives, to processes for their preparation and to pharmaceutical compositions containing them.

Abstract: The present invention provides certain heterocyclic sulfonamide derivatives of formula (I): useful for potentiating glutamate receptor function in a patient and therefore, useful for treating a wide variety of conditions, such as psychiatric and neurological disorders.

Abstract: The present invention relates to the potentiation of glutamate receptor function using certain sulphonamide derivatives. It also relates to novel sulphonamide derivatives, to processes for their preparation and to pharmaceutical compositions containing them.

Abstract: The present invention provides certain amide, carbamate and urea derivatives useful for potentiating glutamate receptor function in a mammal and therefore, useful for treating a wide variety of conditions, such as psychiatric and neurological disorders.

Abstract: The present invention relates to the potentiation of glutamate receptor function using certain sulphonamide derivatives. It also relates to novel sulphonamide derivatives, to processes for their preparation and to pharmaceutical compositions containing them.

Abstract: The present invention describes a facility which may be used in conjunction with SmartCard technology. Application Protocol Data Units (APDUs) are used to communicate with SmartCards. The management of these units is the primary focus and advantage of this facility. Smartcard environments can require that the APDUs conform to an environment specific format, and they can have different methods of sending information to and from a SmartCard. Other tools exist which assist in creation of ADPUs for SmartCard communication, but they are most likely tied to a single SmartCard environment. Application Protocol Data Unit—Management Facility (AMF) has numerous advantages over other APDU generation tools and are described.